Go Pro
NASDAQ:KIDS

OrthoPediatrics Q3 2026 Earnings Report

OrthoPediatrics logo
$22.58 +0.01 (+0.02%)
As of 03:15 PM Eastern
This is a fair market value price provided by Massive. Learn more.

OrthoPediatrics EPS Results

Actual EPS
N/A
Consensus EPS
-$0.25
Beat/Miss
N/A
One Year Ago EPS
N/A

OrthoPediatrics Revenue Results

Actual Revenue
N/A
Expected Revenue
$68.49 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

OrthoPediatrics Announcement Details

Quarter
Q3 2026
Time
After Market Closes
Conference Call Date
Tuesday, October 27, 2026
Conference Call Time
4:30PM ET

Conference Call Resources

OrthoPediatrics Earnings Headlines

OrthoPediatrics Surpasses 1,000 PNP Tibia Nail Implantations
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.tc pixel
OrthoPediatrics (KIDS) Crosses $70M as Guidance Climbs Higher
See More OrthoPediatrics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like OrthoPediatrics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on OrthoPediatrics and other key companies, straight to your email.

About OrthoPediatrics

OrthoPediatrics (NASDAQ:KIDS) (NASDAQ: KIDS) develops, manufactures and sells orthopedic products designed specifically for children. The company focuses on addressing the distinct anatomical and clinical needs of pediatric patients, offering implants, instruments and related technologies for orthopedic surgery.

Its product portfolio includes solutions for pediatric trauma and deformity correction, scoliosis and spinal disorders, sports medicine, limb lengthening and reconstruction, and neuromuscular conditions. The company also provides specialized surgical instruments and systems intended to support orthopedic procedures for infants, children and adolescents.

Founded in 2006 and headquartered in Warsaw, Indiana, OrthoPediatrics markets its products through direct sales and distribution relationships in the United States and international markets. The company became publicly traded in 2017 and has expanded its offerings through internal development and acquisitions, including technologies focused on pediatric spine care.

View OrthoPediatrics Profile